Ignite Creation Date:
2025-12-26 @ 10:37 AM
Ignite Modification Date:
2025-12-29 @ 1:51 PM
Study NCT ID:
NCT00453128
Status:
COMPLETED
Last Update Posted:
2007-03-28
First Post:
2007-03-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D002805', 'term': 'Chondrocalcinosis'}], 'ancestors': [{'id': 'D001168', 'term': 'Arthritis'}, {'id': 'D007592', 'term': 'Joint Diseases'}, {'id': 'D009140', 'term': 'Musculoskeletal Diseases'}, {'id': 'D000070657', 'term': 'Crystal Arthropathies'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'count': 240}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '1997-01'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2007-03', 'completionDateStruct': {'date': '2006-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2007-03-27', 'studyFirstSubmitDate': '2007-03-26', 'studyFirstSubmitQcDate': '2007-03-27', 'lastUpdatePostDateStruct': {'date': '2007-03-28', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2007-03-28', 'type': 'ESTIMATED'}}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Calcium Pyrophosphate', 'associated conditions'], 'conditions': ['Chondrocalcinosis']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to determine whether thorough analytical evaluation is useful to diagnose metabolic conditions associated to calcium pyrophosphate deposition disease.', 'detailedDescription': 'The diagnostic usefulness of screening for hyperparathyroidism, hemochromatosis, hypothyroidism and hypophosphatasia in patients diagnosed with calcium pyrophosphate dihydrate (CPPD) deposition disease is uncertain.\n\nPatients diagnosed with CPPD deposition disease were compared to patients with rheumatoid arthritis and psoriatic arthritis over a 9-year period. All patients were prospectively followed for at least 12 months. Serum calcium, phosphorus, alkaline phosphatase, thyroid-stimulating hormone, ferritin, iron, and total iron binding capacity were determined in all patients.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients diagnosed as having calcium pyrophosphate dihydrate deposition disease.\n\nExclusion Criteria:\n\n* Patients mimicking a rheumatoid arthritis disease, with positive rheumatoid factor or with psoriasis.'}, 'identificationModule': {'nctId': 'NCT00453128', 'briefTitle': 'Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients', 'organization': {'class': 'OTHER', 'fullName': 'Sociedade Galega de Reumatoloxía'}, 'officialTitle': 'Appraisal of the Diagnostic Rentability of Thorough Analytical Screening Searching Associated Conditions in Patients Newly Diagnosed With Calcium Pyrophosphate Dihydrate Deposition Disease', 'orgStudyIdInfo': {'id': 'SGR1'}}, 'contactsLocationsModule': {'locations': [{'zip': '36214', 'city': 'Vigo', 'state': 'Pontevedra', 'country': 'Spain', 'facility': 'Meixoeiro Hospital', 'geoPoint': {'lat': 42.23282, 'lon': -8.72264}}], 'overallOfficials': [{'name': 'José M Pego-Reigosa, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Meixoeiro Hospital, Vigo (Pontevedra) SPAIN'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Sociedade Galega de Reumatoloxía', 'class': 'OTHER'}}}}